Heart Disease Trial, Recruiting NCT06587165 Sponsor: Weill Medical College of Cornell University Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06587165
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Babies between 30 days old and 1 year old who are scheduled for planned (non-emergency) heart surgery may be considered for this trial.
  • Babies in that age range who have a type of heart condition where the surgery is very likely to involve removing a small piece of heart muscle tissue as part of the operation may be considered.
  • Babies with a heart condition called Tetralogy of Fallot with pulmonary stenosis (ToF/PS), or another heart condition where the surgical procedure routinely involves removing a small amount of heart muscle tissue that can then be used for research, may be considered.

Who may not be able to join:

  • Babies who are unlikely to have any heart muscle tissue removed as part of their heart surgery may not be eligible.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bernhard Kuhn, MD, Weill Medical College of Cornell University

Phone: 646-962-9036

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 May 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of labeled cardiomyocytes for each patient

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov